In the current study, dysregulation of lipid metabolism within the PSA gray zone of 4–10 ng/ml in PCa patients compared with BPH patients was firstly explored by LC-MS/MS analysis. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.